RJFSA
GMED icon

Raymond James Financial Services Advisors’s Globus Medical GMED Stock Holding History

Raymond James Financial Services Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$805K Sell
11,247
-236
-2% -$16.7K ﹤0.01% 2304
2024
Q2 		$786K Sell
11,483
-309
-3% -$18.5K ﹤0.01% 2229
2024
Q1 		$633K Buy
11,792
+3,502
+42% +$188K ﹤0.01% 2348
2023
Q4 		$442K Sell
8,290
-662
-7% -$32.3K ﹤0.01% 2502
2023
Q3 		$444K Buy
8,952
+191
+2% +$10.7K ﹤0.01% 2401
2023
Q2 		$522K Sell
8,761
-748
-8% -$42.6K ﹤0.01% 2331
2023
Q1 		$539K Buy
9,509
+3,829
+67% +$246K ﹤0.01% 2289
2022
Q4 		$422K Buy
5,680
+343
+6% +$23.4K ﹤0.01% 2355
2022
Q3 		$318K Buy
5,337
+860
+19% +$51.8K ﹤0.01% 2532
2022
Q2 		$251K Sell
4,477
-355
-7% -$23.3K ﹤0.01% 2715
2022
Q1 		$357K Sell
4,832
-1,239
-20% -$86.1K ﹤0.01% 2585
2021
Q4 		$438K Buy
6,071
+1,124
+23% +$81.6K ﹤0.01% 2463
2021
Q3 		$379K Sell
4,947
-647
-12% -$51.9K ﹤0.01% 2539
2021
Q2 		$434K Buy
5,594
+109
+2% +$7.75K ﹤0.01% 2467
2021
Q1 		$338K Buy
5,485
+23
+0.4% +$1.46K ﹤0.01% 2545
2020
Q4 		$356K Sell
5,462
-4,347
-44% -$250K ﹤0.01% 2361
2020
Q3 		$486K Sell
9,809
-6,777
-41% -$350K ﹤0.01% 1984
2020
Q2 		$791K Buy
16,586
+6,944
+72% +$335K ﹤0.01% 1629
2020
Q1 		$410K Buy
9,642
+52
+0.5% +$2.57K ﹤0.01% 1667
2019
Q4 		$565K Sell
9,590
-113
-1% -$6.13K ﹤0.01% 1890
2019
Q3 		$496K Buy
9,703
+194
+2% +$9.24K ﹤0.01% 1906
2019
Q2 		$402K Buy
9,509
+5,111
+116% +$222K ﹤0.01% 2065
2019
Q1 		$217K Buy
+4,398
New +$199K ﹤0.01% 2446
2018
Q4 		– Sell
-4,114
Closed -$234K – 2654
2018
Q3 		$234K Sell
4,114
-1,851
-31% -$97.4K ﹤0.01% 2430
2018
Q2 		$301K Buy
+5,965
New +$311K ﹤0.01% 2226

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Raymond James Financial Services Advisors's GMED Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Globus Medical (GMED) stake by 2.1% in Q3 2024, selling an estimated $16.7K and leaving 11,247 shares worth $805K. The position accounts for ﹤0.01% of the portfolio, ranked #2304.

Raymond James Financial Services Advisors first reported a position in GMED in Q2 2018 and has held it in 25 quarters since. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Raymond James Financial Services Advisors held 11,247 shares of Globus Medical worth $805K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 236 Globus Medical shares in Q3 2024, an estimated $16.7K.
  • Globus Medical made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2304 holding.
  • Raymond James Financial Services Advisors first reported a position in Globus Medical in Q2 2018 and has held it in 25 quarters since.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.